CD8A and neoplasm: In a separate experiment where T-cell subsets were depleted two weeks later, i.e. simultaneously with tumor cell inoculation, hence allowing the pCT26-5 immune response to initiate before depletion, we observed again how CD8+ T cells were required to obtain tumor control (Supplementary Fig. 2).